Cargando…
Cushing’s Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat
Cushing’s syndrome (CS), secondary to paraneoplastic syndrome, is more commonly seen in small cell lung cancer but never before reported in epidermal growth factor receptor-mutated adenocarcinoma of the lung. Here, we present a case of a patient whose symptoms of hypokalemia, hypertension, and progr...
Autores principales: | Heleno, Caio Teixeira, Hong, Seung Pyo D., Cho, Hyung-Gyo, Kim, Min Jeong, Park, Yeonggyeong, Chae, Young Kwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978924/ https://www.ncbi.nlm.nih.gov/pubmed/36876215 http://dx.doi.org/10.1159/000527824 |
Ejemplares similares
-
Adrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy
por: Malik, Risha B., et al.
Publicado: (2022) -
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease
por: Gadelha, Mônica, et al.
Publicado: (2022) -
Osilodrostat‐induced adrenal insufficiency in a patient with Cushing's disease
por: Ekladios, Catherine, et al.
Publicado: (2022) -
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples
por: Fleseriu, Maria, et al.
Publicado: (2022) -
Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat
por: Blew, Kathryn, et al.
Publicado: (2023)